|
|
||||||||
Original Research Communication |
1 From the Departments of Endocrinology and Metabolism, Clinical Chemistry Laboratory of Endocrinology, and Biochemistry, Academic Medical Center, University of Amsterdam; the Center for Liver, Digestive and Metabolic Diseases, Academic Hospital Groningen, Groningen, Netherlands; and the Departments of Internal Medicine and Endocrinology, Leiden University Medical Center, Leiden, Netherlands.
2 Supported by grant 96.604 from the Dutch Diabetes Foundation.
3 Address reprint requests to PHLT Bisschop, Department of Endocrinology and Metabolism (F5), Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, Netherlands. E-mail: p.h.bisschop{at}amc.uva.nl.
| ABSTRACT |
|---|
|
|
|---|
Objective: The aim was to compare the effect of different amounts of dietary fat on hepatic and peripheral insulin sensitivity.
Design: Six healthy men were studied on 3 occasions after consuming for 11 d diets with identical energy and protein contents but different percentages of energy as fat and carbohydrate as follows: 0% and 85% [low-fat, high-carbohydrate (LFHC) diet], 41% and 44% [intermediate-fat, intermediate-carbohydrate (IFIC) diet], and 83% and 2% [high-fat, low-carbohydrate (HFLC) diet]. Insulin sensitivity was quantified by using a hyperinsulinemic euglycemic clamp (plasma insulin concentration:
190 pmol/L).
Results: During hyperinsulinemia, endogenous glucose production was higher after the HFLC diet (2.5 ± 0.3 µmolkg-1min-1; P < 0.05) than after the IFIC and LFHC diets (1.7 ± 0.3 and 1.2 ± 0.4 µmolkg-1min-1, respectively). The ratio of dietary fat to carbohydrate had no unequivocal effects on insulin-stimulated glucose uptake. In contrast, insulin-stimulated, nonoxidative glucose disposal tended to increase in relation to an increase in the ratio of fat to carbohydrate, from 14.8 ± 5.1 to 20.6 ± 1.9 to 26.2 ± 2.9 µmolkg-1min-1 (P < 0.074 between the 3 diets). Insulin-stimulated glucose oxidation was significantly lower after the HFLC diet than after the IFIC and LFHC diets: 1.7 ± 0.8 compared with 13.4 ± 2.1 and 19.0 ± 2.1 µmolkg-1min-1, respectively (P < 0.05). During the clamp study, plasma fatty acid concentrations were higher after the HFLC diet than after the IFIC and LFHC diets: 0.22 ± 0.02 compared with 0.07 ± 0.01 and 0.05 ± 0.01 mmol/L, respectively (P < 0.05).
Conclusion: A high-fat, low-carbohydrate intake reduces the ability of insulin to suppress endogenous glucose production and alters the relation between oxidative and nonoxidative glucose disposal in a way that favors storage of glucose.
Key Words: Glucose metabolism insulin dietary fat dietary carbohydrate euglycemic clamp glucose turnover rate men
| INTRODUCTION |
|---|
|
|
|---|
400 pmol/L was not significantly different after 16 d of diets containing either
25% or
50% fat. At comparable insulin concentrations, Cutler et al (3) showed that even intakes of diets containing
75% of energy as fat did not alter peripheral or hepatic insulin sensitivity. However, insulin concentrations of 400 pmol/L result in complete suppression of endogenous glucose production (4) and are therefore less suitable for quantifying hepatic insulin sensitivity. Fukagawa et al (5) compared the effect of a habitual diet containing
40% of energy as fat with that of a diet containing 15% of energy as fat at lower insulin concentrations (
200 pmol/L). They found a modest increase in peripheral insulin sensitivity after the low-fat diet, but no difference in hepatic insulin sensitivity. In humans, evidence of a possible dose-effect relation between dietary fat content and insulin sensitivity, on the basis of physiologically relevant insulin concentrations and the entire spectrum of isoenergetic dietary fat content, has not been documented. Therefore, we studied the effects of 3 euenergetic diets representing a wide range of fat contents (from 0% to 83% of energy) on insulin sensitivity in 6 healthy men. We used a hyperinsulinemic, euglycemic clamp to produce plasma insulin concentrations of 200 pmol/L to determine both hepatic and peripheral insulin sensitivity.
| SUBJECTS AND METHODS |
|---|
|
|
|---|
Diets
The subjects were studied on 3 occasions, each time after they had consumed a different diet for 11 d. The experiments in each subject were separated by an interval of 810 wk, during which time the subjects resumed their habitual diets. The sequence of the 3 studies was determined by balanced assignment. The 3 diets consisted of liquid formulas containing identical amounts of protein (15% of energy) and an identical protein composition. The diets were custom-made (Nutricia, Zoetermeer, Netherlands). The low-fat, high-carbohydrate (LFHC) diet provided 0% of energy as fat and 85% of energy as carbohydrate; the intermediate-fat, intermediate-carbohydrate (IFIC) diet provided 41% of energy as lipids and 44% of energy as carbohydrate; and the high-fat, low-carbohydrate (HFLC) diet provided 83% of energy as lipids and 2% of energy as carbohydrate. The ratio of saturated to monounsaturated to polyunsaturated lipids was 2:2:1 for the 2 diets that contained fat and all 3 diets contained
15 g fiber.
The energy requirements of each subject were assessed by a dietitian by means of a 3-d dietary journal. Liquid meals with predetermined amounts of energy were consumed at 6 fixed time points each day between 0800 and 2130 for 11 d. Compliance with the diets was assessed by measuring the respiratory quotient, which reflects the ratio of carbohydrate to fat intake (6). Respiratory quotients were measured after 10 and 11 d of the experimental diet, after an overnight fast. Subjects refrained from alcohol consumption during the experimental diets and physical activity was limited to usual daily activities. In addition to the diets, the subjects were allowed to drink only water ad libitum.
Protocol
The subjects were admitted to the Clinical Research Center and studied in the supine position. At 0700, after the subjects had fasted overnight (for 14 h), a catheter was inserted into an antecubital vein of each arm. One catheter was used to sample arterialized blood with use of a heated hand box (60°C). The other catheter was used to infuse [6,6-2H2]glucose, a 20%-glucose solution, and insulin. At 0900, after a blood sample was taken to measure the background enrichment of plasma glucose, a primed, continuous infusion of [6,6-2H2]glucose (>99% enriched; Cambridge Isotope Laboratories, Cambridge, MA) was started at a rate of 0.33 µmolkg-1min-1 (prime: 26.7 µmol/kg). After 150, 165, and 180 min, blood samples were drawn for measurement of basal endogenous glucose production and fatty acid concentrations. At 1200, a primed, continuous infusion of insulin (100 kU Actrapid/L; Novo Nordisk Farma BV, Zoeterwoude, Netherlands) was started at a rate of 20 mUm body surface area-2min-1. Plasma glucose concentrations were measured every 5 min with a Glucose Analyzer 2 (Beckman, Palo Alto, CA) and the 20%-glucose solution was infused at a variable rate to maintain euglycemia at 5.0 mmol/L. [6,6-2H2]Glucose was added to the infusate containing the 20%-glucose solution to achieve glucose enrichments of 2%. This was done to minimize changes in isotopic enrichment resulting from changes in the infusion rate of exogenous glucose and thus to allow for accurate quantification of endogenous glucose production (7, 8). Blood samples were taken for isotopic enrichment of plasma glucose and insulin and fatty acid concentrations 180, 195, and 210 min after the insulin infusion began. During the study, subjects were allowed to drink only water.
Indirect calorimetry
Oxygen consumption (
O2) and carbon dioxide production (
CO2) were measured with the ventilated-hood technique (model 2900; Sensormedics, Anaheim, CA).
and
CO2 were measured continuously at basal insulin concentrations from 1130 to 1200 and between 180 and 210 min after initiation of the hyperinsulinemic euglycemic clamp. The mean rates of
and
CO2 from 1140 to 1200 and between 190 and 210 min of hyperinsulinemia were used to calculate glucose and fat oxidation as described below.
Gas chromatographymass spectrometry
Plasma samples for glucose enrichment of [6,6-2H2]glucose were deproteinized with methanol (9). The aldonitril pentaacetate derivative of glucose (10) was injected into a gas chromatograph mass spectrometer system (HP 6890 series II gas chromatograph equipped with a split-splitless injector and an HP 5973 model mass selective detector; Hewlett-Packard, Palo Alto, CA). Separation was achieved on a DB17 column (30 m x 0.25 mm, film thickness of 0.25 µm; J&W Scientific, Folsom, CA). Glucose was monitored at mass-to-charge ratios of 187, 188, and 189. Within each series, 3 control samples with known enrichments were measured for quality control. Glucose enrichments were calculated by dividing the area of the mass-to-charge 189 peak by total peak area. Xylose was used as an internal standard to measure glucose concentrations.
Analytic procedures
The plasma insulin concentration was determined by radioimmunoassay (Insulin RIA 100; Pharmacia Diagnostic AB, Uppsala, Sweden) with an intraassay CV of 35%, an interassay CV of 69%, and a detection limit of 15 pmol/L. Serum fatty acids were measured with an enzymatic method (NEFAC; Wako Chemicals GmbH, Neuss, Germany) with an intraassay CV of 24%, an interassay CV of 36%, and a detection limit of 0.02 mmol/L.
Calculations and statistics
When endogenous glucose production (Ra) and glucose disposal (Rd) are calculated, the added source of labeled glucose entering the system and the exogenous glucose infusate should be taken into account. Thus, Ra and Rd were calculated with a modified form of the Steele equations as described by Finegood et al (11):
![]() |
and
![]() |
where I is the constant tracer infusion rate (mgkg-1min-1), t is time, Pctp(t) is the percentage enrichment in plasma glucose taken as the average of 2 consecutive samples, p is the pool fraction, V is the distribution volume of glucose, G(t) is the plasma glucose concentration taken as the average of 2 consecutive samples, dPctp(t)/dt is the rate of change in the percentage enrichment in plasma (min-1), GInf(t) is the rate of infusion of exogenous glucose, Pctg is the percentage enrichment of the glucose infusate, and dG(t)/dt is the rate of change in the plasma glucose concentration; V (pV) was set at 165 mL/kg. All percentages were corrected for background percentages by subtracting the basal percentage. Reported Ra and Rd values represent the mean values from 180 to 210 min after the insulin infusion began. Glucose and fat oxidation were calculated from
CO2,
CO2, and urinary nitrogen excretion (12).
The overall effects of the diets were analyzed at basal insulin concentrations and, separately, during hyperinsulinemia by using the Friedman test, which is the nonparametric equivalent of two-way analysis of variance. When the P value was <0.05, a post hoc analysis with Wilcoxon's signed-rank test was conducted to test for differences between the individual diets. The differences between basal and hyperinsulinemic conditions within each diet were analyzed by Wilcoxon's signed-rank test. A P value <0.05 was considered to indicate a significant difference. Data are presented as means ± SEs. We used SPSS (SPSS Inc, Chicago) for the statistical analyses.
| RESULTS |
|---|
|
|
|---|
Plasma insulin concentrations and glucose kinetics
Basal plasma insulin concentrations were 38 ± 3, 37 ± 3, and 25 ± 4 pmol/L after the LFHC, IFIC, and HFLC diets, respectively (LFHC and IFIC diets compared with the HFLC diet: P < 0.05 ). During the hyperinsulinemic clamp study, insulin concentrations were 193 ± 12, 189 ± 12, and 174 ± 8 pmol/L, respectively (NS).
Basal plasma glucose concentrations were 5.17 ± 0.17, 5.11 ± 0.11, and 4.65 ± 0.21 mmol/L, respectively (LFHC and IFIC diets compared with the HFLC diet: P < 0.05). During the hyperinsulinemic clamp, glucose concentrations were 4.9 ± 0.04, 4.9 ± 0.04, and 4.9 ± 0.07 mmol/L, respectively (NS). The rates of endogenous glucose production are presented in Table 1
. Basal endogenous glucose production was inversely related to the dietary fat content. Insulin decreased endogenous glucose production in all diet groups, but was less effective after the HFLC diet (P = 0.002).
|
|
|
| DISCUSSION |
|---|
|
|
|---|
The diets used in the present study provided a wide range of fat intakes, from 0% to 83% of total energy. Because the diets were euenergetic, higher fat intakes inevitably led to lower carbohydrate intakes. This approach was used to avoid the influence of overfeeding or underfeeding on endogenous glucose production and insulin-mediated peripheral glucose metabolism. In a typical ad libitum high-fat diet, energy intake usually increases, which should be borne in mind when comparisons are made with the HFLC diet used in the present study. In addition, liquid diets contain a higher percentage of simple sugars than do solid-food diets. It was shown previously that carbohydrate composition affects fatty acid synthesis (13). Because the effects of carbohydrate composition on insulin action remain to be elucidated, caution should be exercised when making generalizations about diets consumed by the general population.
The present study showed that insulin was less effective in suppressing endogenous glucose production after the HFLC diet than after the other 2 diets. Insulin suppresses endogenous glucose production via direct effects on the liver, but also indirectly via a reduction in fatty acid concentrations (1416). In the present study, this indirect effect of insulin was inhibited by the HFLC diet because fatty acid concentrations were suppressed less effectively during the hyperinsulinemic clamp compared with the other 2 diets. Because, in general, there is a positive relation between fatty acid concentrations and the rate of appearance of fatty acids, which reflects the rate of lipolysis, these observations indicate insulin resistance with respect to the effects of insulin on lipolysis. It is possible that the impaired action of insulin on endogenous glucose production after the HFLC diet was related to the higher fatty acid concentrations during the hyperinsulinemic clamp (17). In the postabsorptive state, both plasma insulin concentrations and endogenous glucose production were lower after the HFLC diet than after the other 2 diets. This finding suggests that hepatic insulin sensitivity increased. However, this may not merely be a reflection of altered insulin sensitivity, but rather a different mechanismhepatic glycogen depletion (18, 19).
The effect of the dietary fat content on insulin sensitivity with respect to the effects of insulin on glucose disposal was not conclusive because insulin sensitivity was not significantly different between the high- and low-fat diets even though we established a maximum euenergetic difference in fat intake. Thus, there appears to be no dose-response relation between the dietary (euenergetic) fat content and peripheral insulin sensitivity with respect to the effects of insulin on glucose disposal. Our findings support the notion expressed in the literature that dietary fat does not directly cause peripheral insulin resistance with respect to glucose uptake (2, 3, 20).
Even though the dietary fat content did not conclusively alter total glucose disposal, there were marked effects of dietary fat content on both oxidative and nonoxidative glucose disposal. Higher dietary fat contents resulted in increased insulin-stimulated nonoxidative glucose disposal and reduced carbohydrate oxidation, suggesting that insulin stimulates glycogen synthesis more effectively when dietary fat intakes increase and carbohydrate intakes decrease. This agrees with the increase in glycogen synthase activity by insulin observed after the consumption of high-fat diets (3). In contrast, the HFLC diet inhibited the stimulatory effects of insulin on glucose oxidation. Therefore, a high-fat, low-carbohydrate diet appears to result in a dissociation with respect to the effects of insulin on oxidative and nonoxidative glucose pathways.
A high-fat, low-carbohydrate diet should cause an increase in ketone production and oxidation. Ketones that are produced, but not oxidized, generate a respiratory quotient of 0, which tends to decrease the overall respiratory quotient and result in underestimated glucose oxidation rates. To quantify the potential effect induced by this metabolic process, we measured the amount of urinary 3-hydroxybutyrate excretion during the last 24 h of the HFLC diet (4.5 ± 1.4 mmol/24 h). Assuming that this amount represents the amount of 3-hydroxybutyrate produced but not oxidized,
O2 will be overestimated by <0.00004%, which is negligible. It is unlikely that other ketone bodies could have resulted in an important overestimation of
O2 because this would mean that excretion of other ketone bodies compared with 3-hydroxybutyrate should be
100000 fold higher to overestimate
O2 by 1%. Therefore, it is unlikely that production without subsequent oxidation of ketone bodies during the HFLC diet would have influenced the results.
It can be assumed that mean 24-h insulin concentrations were lower during the HFLC diet because the main stimulus for insulin secretion, ie, carbohydrate intake, was absent. Under normal circumstances, ie, after the IFIC diet, insulin readily enhances glucose oxidation and suppresses lipid oxidation, but this effect of insulin did not occur after the HFLC diet. Even 3 h of hyperinsulinemia did not suppress fat oxidation or increase glucose oxidation. This might have been due to altered fuel selection because the main energy substrates during 11 d of the HFLC diet were fatty acids, as judged from enhanced fat oxidation and near complete lack of glucose oxidation. In line with this notion is the fact that fatty acid concentrations were higher during hyperinsulinemia after the HFLC diet. Because the HFLC diet provided virtually no carbohydrates for 11 d, it is likely that the enhanced effect of insulin on glycogen synthesis in muscle and the decreased effect on glucose oxidation after the HFLC diet are physiologic adaptations to carbohydrate deprivation and subsequent depletion of glycogen (21, 22). Thus, the consumption of high-fat, low-carbohydrate diets in healthy subjects induces a series of adaptations in peripheral glucose metabolism and insulin action resulting in glucose sparing and repletion of glycogen stores.
During the consumption of high-fat, low-carbohydrate diets, fat is the major fuel source, as evidenced by a respiratory quotient of
0.7. Similar fuel selection occurs during starvation (23). Because of this similarity it was of interest to compare the effects of high-fat, low-carbohydrate diets with the known effects of starvation on hormonal and metabolic changes. Both high-fat, low-carbohydrate diets and starvation decrease insulin concentrations, basal glucose production, and basal glucose oxidation, whereas both conditions increase lipolysis. In addition, both conditions are known to decrease insulin-stimulated glucose oxidation (24). In contrast with these similarities, there are also distinct differences between the effects of high-fat, low-carbohydrate diets and starvation. For instance, high-fat, low-carbohydrate diets do not induce peripheral insulin resistance with respect to glucose uptake and stimulate nonoxidative glucose disposal, whereas starvation reduces insulin-mediated glucose uptake (2426) and does not increase nonoxidative glucose disposal (24). Thus, although the effects of high-fat, low-carbohydrate diets and starvation on basal fuel selection are comparable, the effects are clearly different with respect to insulin-stimulated peripheral glucose metabolism.
High fat intakes are associated with insulin resistance and type 2 diabetes. In type 2 diabetes, the most apparent defect in peripheral glucose metabolism is diminished insulin-stimulated glucose uptake (27), resulting in decreased intracellular glucose availability. Consequently, both glycogen synthesis and glucose oxidation are impaired in patients with type 2 diabetes (28). When glucose transport was experimentally increased to normal concentrations (by hyperinsulinemia or hyperglycemia), only glucose oxidation remained impaired; glycogen synthesis was restored (29, 30). In contrast with the findings for type 2 diabetes, consumption of the HFLC diet in the present study did not conclusively suppress insulin-stimulated glucose transport. Although glucose transport, measured as glucose disposal, was not affected by a high fat intake, glucose oxidation was
90% lower after the HFLC diet. As mentioned above, glucose oxidation is also impaired in diabetes, but not to the same extent (2628%) (30). Therefore, the alterations in insulin-mediated peripheral glucose metabolism induced by the HFLC diet in the present study differed both qualitatively and quantitatively from those characteristic of type 2 diabetes.
In conclusion, diets with a high-fat, low-carbohydrate content have differential effects on insulin action. High-fat, low-carbohydrate diets impair the action of insulin on endogenous glucose production, glucose oxidation, and probably lipolysis, whereas high-fat, low-carbohydrate diets do not unequivocally affect the action of insulin on total glucose disposal and tend to enhance the action of insulin on nonoxidative glucose disposal. Despite the large differences in the fat contents of the diets studied, we could not establish a dose-response relation between dietary fat content and all aspects of insulin sensitivity. Remarkably, in the context of diabetes risk, 2 aspects of glucose homeostasis actually improved after consumption of the HFLC diet: decreased basal endogenous glucose production and improved insulin-stimulated nonoxidative glucose disposal. This observation might prove critical in the design of future studies.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Tay, G. D. Brinkworth, M. Noakes, J. Keogh, and P. M. Clifton Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J. Am. Coll. Cardiol., January 1, 2008; 51(1): 59 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C Westman, R. D Feinman, J. C Mavropoulos, M. C Vernon, J. S Volek, J. A Wortman, W. S Yancy, and S. D Phinney Low-carbohydrate nutrition and metabolism Am. J. Clinical Nutrition, August 1, 2007; 86(2): 276 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chokkalingam, K. Jewell, L. Norton, J. Littlewood, L. J. C. van Loon, P. Mansell, I. A. Macdonald, and K. Tsintzas High-Fat/Low-Carbohydrate Diet Reduces Insulin-Stimulated Carbohydrate Oxidation but Stimulates Nonoxidative Glucose Disposal in Humans: An Important Role for Skeletal Muscle Pyruvate Dehydrogenase Kinase 4 J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 284 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. McAuley and J. Mann Thematic review series: Patient-Oriented Research. Nutritional determinants of insulin resistance J. Lipid Res., August 1, 2006; 47(8): 1668 - 1676. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sunehag, G. Toffolo, M. Campioni, D. M. Bier, and M. W. Haymond Effects of Dietary Macronutrient Intake on Insulin Sensitivity and Secretion and Glucose and Lipid Metabolism in Healthy, Obese Adolescents J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4496 - 4502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Allick, P. H. Bisschop, M. T. Ackermans, E. Endert, A. J. Meijer, F. Kuipers, H. P. Sauerwein, and J. A. Romijn A Low-Carbohydrate/High-Fat Diet Improves Glucoregulation in Type 2 Diabetes Mellitus by Reducing Postabsorptive Glycogenolysis J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6193 - 6197. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lara-Castro and W. T. Garvey Diet, Insulin Resistance, and Obesity: Zoning in on Data for Atkins Dieters Living in South Beach J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4197 - 4205. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Volek, M. J. Sharman, A. L. Gomez, C. DiPasquale, M. Roti, A. Pumerantz, and W. J. Kraemer Comparison of a Very Low-Carbohydrate and Low-Fat Diet on Fasting Lipids, LDL Subclasses, Insulin Resistance, and Postprandial Lipemic Responses in Overweight Women J. Am. Coll. Nutr., April 1, 2004; 23(2): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Anderson, C. W.C. Kendall, and D. J.A. Jenkins Importance of Weight Management in Type 2 Diabetes: Review with Meta-analysis of Clinical Studies J. Am. Coll. Nutr., October 1, 2003; 22(5): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Bisschop, M. G. M. de Sain-van der Velden, F. Stellaard, F. Kuipers, A. J. Meijer, H. P. Sauerwein, and J. A. Romijn Dietary Carbohydrate Deprivation Increases 24-Hour Nitrogen Excretion without Affecting Postabsorptive Hepatic or Whole Body Protein Metabolism in Healthy Men J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3801 - 3805. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. MacIntosh, S. H. A. Holt, and J. C. Brand-Miller The Degree of Fat Saturation Does Not Alter Glycemic, Insulinemic or Satiety Responses to a Starchy Staple in Healthy Men J. Nutr., August 1, 2003; 133(8): 2577 - 2580. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. V. Axen, A. Dikeakos, and A. Sclafani High Dietary Fat Promotes Syndrome X in Nonobese Rats J. Nutr., July 1, 2003; 133(7): 2244 - 2249. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Pagliassotti, Y. Wei, and M. E. Bizeau Glucose-6-Phosphatase Activity Is Not Suppressed but the mRNA Level Is Increased by a Sucrose-Enriched Meal in Rats J. Nutr., January 1, 2003; 133(1): 32 - 37. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Sunehag, G. Toffolo, M. S. Treuth, N. F. Butte, C. Cobelli, D. M. Bier, and M. W. Haymond Effects of Dietary Macronutrient Content on Glucose Metabolism in Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5168 - 5178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Commerford, J. B. Ferniza, M. E. Bizeau, J. S. Thresher, W. T. Willis, and M. J. Pagliassotti Diets enriched in sucrose or fat increase gluconeogenesis and G-6-Pase but not basal glucose production in rats Am J Physiol Endocrinol Metab, September 1, 2002; 283(3): E545 - E555. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sharman, W. J. Kraemer, D. M. Love, N. G. Avery, A. L. Gomez, T. P. Scheett, and J. S. Volek A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Normal-Weight Men J. Nutr., July 1, 2002; 132(7): 1879 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. N Das Long-chain polyunsaturated fatty acids and diabetes mellitus Am. J. Clinical Nutrition, April 1, 2002; 75(4): 780 - 781. [Full Text] [PDF] |
||||
![]() |
M. J. Pagliassotti, J. Kang, J. S. Thresher, C. K. Sung, and M. E. Bizeau Elevated basal PI 3-kinase activity and reduced insulin signaling in sucrose-induced hepatic insulin resistance Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E170 - E176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Voshol, M. C. Jong, V. E.H. Dahlmans, D. Kratky, S. Levak-Frank, R. Zechner, J. A. Romijn, and L. M. Havekes In Muscle-Specific Lipoprotein Lipase-Overexpressing Mice, Muscle Triglyceride Content Is Increased Without Inhibition of Insulin-Stimulated Whole-Body and Muscle-Specific Glucose Uptake Diabetes, November 1, 2001; 50(11): 2585 - 2590. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |